Charles River Laboratories (CRL) Tops Q4 EPS by 18c, Revenues Beat; Offers FY20 EPS Guidance Above Consensus
Go back to Charles River Laboratories (CRL) Tops Q4 EPS by 18c, Revenues Beat; Offers FY20 EPS Guidance Above Consensus| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 280.05 -1.22 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $281.27 | 52 Week High | $89.18 | |||
| Open | $280.06 | 52 Week Low | $65.70 | |||
| Day High | $283.20 | P/E | 130.26 | |||
| Day Low | $276.66 | EPS | $2.15 | |||
| Volume | 750,354 | |||||
